For years, a triglyceride test came with a small ritual attached. No food, no drink besides water, for twelve hours beforehand, ideally an early morning appointment so the fast would not stretch into lunch. That instruction has been quietly disappearing from routine bloodwork. Not because the test changed, but because the evidence behind the fasting rule turned out to be thinner than the rule itself.
What a triglyceride actually is
Triglycerides are the most common fat in the body, and one of the more misunderstood entries on a standard lipid panel. When you eat more calories than you use right away, the body packages the surplus into triglycerides and stores them in fat cells for later. Between meals, hormones release that stored fat back into the bloodstream so tissues have fuel to draw on. In other words, a rising triglyceride number after a meal is not a malfunction. It is the system doing exactly what it is built to do, moving fuel that was just eaten into storage and circulation at once.
The complication is that triglycerides do not travel through the blood alone. They ride inside lipoprotein particles, chylomicrons straight from a meal and VLDL made by the liver, both of which also ferry cholesterol. That shared transport is why a triglyceride result has always been read alongside the rest of the lipid panel rather than on its own. It is also why a fatty meal was long assumed to throw the whole panel off.
Why fasting became the rule
The twelve-hour fast was never really about triglycerides in isolation. It was about protecting the arithmetic used to calculate LDL cholesterol, the Friedewald formula, which estimates LDL from total cholesterol, HDL, and triglycerides divided by five. That equation gets unreliable when triglycerides spike, and clinicians assumed a normal meal could cause exactly that kind of spike. Fasting was the simplest way to remove the variable and standardize the reading.
It was a reasonable precaution built on an untested assumption. Later research found that the rise in triglycerides after an ordinary meal is far smaller than the rise seen after the kind of deliberate high-fat load used in a formal fat-tolerance test, which was really the scenario the original caution was modeled on.
The evidence that changed it
The case for fasting quietly weakened once researchers pointed out something obvious in hindsight: people spend most of their lives in a nonfasting state, not a fasted one. A nonfasting reading arguably reflects the conditions the arteries actually deal with, day to day, more faithfully than one taken after twelve hours of nothing but water.
That reframing held up under scrutiny. Multiple studies since have found that postprandial triglyceride levels are at least as predictive of cardiovascular risk as fasting levels, and in some analyses the association is stronger. Part of the explanation is mechanical: the triglyceride-carrying remnant particles most tied to artery damage are often better captured in the hours after eating than after a long fast, which can mask abnormalities in fat metabolism that only show up once food is back in the system. That masking effect is especially relevant for people with metabolic syndrome, diabetes, or certain inherited lipid conditions, exactly the groups a lipid panel is most often ordered to evaluate.
The practical differences turned out to be modest almost everywhere else on the panel. HDL barely moves between a fasted and fed state. Total cholesterol and LDL run only slightly lower, by roughly eight points, when measured nonfasting. Triglycerides are the outlier, running up to about 25 points higher nonfasting, a real but usually small shift, and not one that changes a clinician's read of overall risk in most cases.
Where the guidelines stand now
A 2016 joint consensus statement from the European Atherosclerosis Society and the European Federation of Clinical Chemistry and Laboratory Medicine was among the first major bodies to recommend nonfasting lipid testing as the default, reserving fasting for specific situations, and it proposed a separate nonfasting flag of 175 mg/dL, higher than the traditional 150 mg/dL fasting cutoff, to account for the expected rise. US guidance followed a similar path. The 2018 AHA/ACC cholesterol guideline allows either a fasting or nonfasting lipid profile for adults not already on lipid-lowering medication, with a repeat fasting test recommended only if a nonfasting triglyceride result comes back at 400 mg/dL or higher.
Fasting has not disappeared from the picture entirely. A 2021 American College of Cardiology expert consensus pathway still calls for a fasting lipid panel, measured at least twice, roughly two weeks apart, before starting triglyceride-targeted drug therapy, and clinicians may still request a fasting sample when screening for an inherited lipid disorder or evaluating the triglyceride component of metabolic syndrome, where a stable, standardized baseline matters more than everyday convenience. For a routine cardiovascular risk check, though, skipping breakfast before the draw is no longer the requirement it once was.
Reading your own number
The categories clinicians use are built around fasting values: a fasting triglyceride level under 150 mg/dL is considered normal, with a level under 100 mg/dL viewed as the more ideal target, 150 to 199 mg/dL as borderline high, 200 to 499 mg/dL as high, and 500 mg/dL or above as severely high and worth prompt attention because of the added risk of pancreatitis at that level. A nonfasting sample is read against the slightly higher 175 mg/dL flag rather than the 150 mg/dL fasting line, since eating alone accounts for some of the difference.
What actually pushes the number up over time is a familiar list: eating more calories than you burn, particularly from sugar and refined carbohydrates, heavier alcohol intake, limited physical activity, and carrying excess weight. It also rises with certain underlying conditions such as poorly controlled diabetes, an underactive thyroid, kidney or liver disease, and some inherited lipid disorders that run in families independent of diet. High triglycerides rarely cause symptoms on their own, which is part of why the number is worth knowing rather than waiting to feel something before checking it.
Common questions
Do I actually need to fast before a triglyceride test? For most routine cardiovascular risk screening, no. Current guidelines allow either a fasting or nonfasting sample for adults who are not on lipid-lowering medication. Fasting is still requested in narrower situations, such as before starting certain triglyceride-lowering treatments, when screening for an inherited lipid disorder, or when a nonfasting result comes back very high and needs confirming.
What counts as a healthy triglyceride level? On a fasting panel, under 150 mg/dL is considered normal, with under 100 mg/dL viewed as more ideal. On a nonfasting panel, the flag for an elevated result sits a bit higher, at 175 mg/dL, to account for the modest rise that eating produces.
Are triglycerides the same thing as cholesterol? No. Both are lipids that travel through the blood packaged inside the same lipoprotein particles, but they are chemically different substances with different jobs. Triglycerides store and transport energy; cholesterol builds cell membranes and hormones. It is common to have both numbers elevated together, since they share so much of the same transport system, but a person can have one abnormal without the other.
Why did my number look different when I ate beforehand? Eating produces a real but usually modest rise in triglycerides, on the order of up to about 25 mg/dL above a fasting value, while HDL, LDL, and total cholesterol shift far less. That is exactly why nonfasting testing now carries its own, slightly higher reference threshold rather than being read against the fasting cutoff.
How often should this test be repeated? Recommendations vary somewhat by source, but a healthy adult with no particular risk factors is generally advised to have a lipid profile roughly every four to six years. People with diabetes, a family history of high triglycerides or heart disease, or other cardiovascular risk factors are typically tested more often, sometimes annually, at their clinician's direction.
